IP Library › Patent Application 17475616
Patent Application Utility
App. No. 17/475,616 · Confirmation No. 4926

Arterial Drug Eluting Device to Treat Diabetes With Targeted Delivery of Medication

Applicant: Embecta Corp.
Abandoned -- Failure to Respond to an Office Action View Publication ↗
⬇ PDF
 Code Description Pages PDF
2025-01-03 ABN Abandonment 2 View
2024-04-30 CTRS Requirement for Restriction/Election 9 View
2022-05-16 IDS Information Disclosure Statement (IDS) Form (SB08) 4 View
2022-05-16 FOR Foreign Reference 7 View
2022-05-16 N417 Electronic Filing System Acknowledgment Receipt 3 View
2022-04-29 APP.FILE.REC Filing Receipt 3 View
2022-04-29 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2022-04-26 PA.. Power of Attorney 2 View
2022-04-26 R46C.REQ Request under 37CFR1.46(c) to correct, update, change applicant 2 View
2022-04-26 ADS Application Data Sheet 6 View
2022-04-26 R3.73 Assignee showing of ownership per 37 CFR 3.73 132 View
2022-04-26 N417 Electronic Filing System Acknowledgment Receipt 2 View
2022-03-24 NTC.PUB Notice of Publication 1 View
2021-09-28 WFEE Fee Worksheet (SB06) 1 View
2021-09-28 APP.FILE.REC Filing Receipt 3 View
2021-09-15 IDS Information Disclosure Statement (IDS) Form (SB08) 4 View
2021-09-15 ADS Application Data Sheet 8 View
2021-09-15 DRW Drawings-only black and white line drawings 2 View
2021-09-15 SPEC Specification 32 View
2021-09-15 CLM Claims 4 View
2021-09-15 ABST Abstract 1 View
2021-09-15 OATH Oath or Declaration filed 2 View
2021-09-15 OATH Oath or Declaration filed 2 View
2021-09-15 WFEE Fee Worksheet (SB06) 2 View
2021-09-15 N417 Electronic Filing System Acknowledgment Receipt 4 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
17/475,616
Filed
2021-09-15
Pub. No.
US20220087839A1
Art Unit
3774